tirzepatide 0.5 mg Mounjaro (Tirzepatide) Injection 7.5 mg/0.5 mL Syringes The FDA says the Zepbound

Typically, multiple sessions spaced several weeks apart are needed to achieve optimal results

[1] [2] You can report any suspected side effects to the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app

Scientific Context and Clinical Relevance In early clinical trials, Retatrutide demonstrated significant effects on energy expenditure and glucose control when used in weekly dosing schedules

However, rapid weight loss can sometimes come with an unwanted side effect: muscle loss alongside fat loss

Who It's For Adults seeking maximum pharmaceutical weight management support, especially those who may have plateaued on single-pathway GLP-1 medications

See Important Safety Information for the full list